Tao, Tao <br/><br/>
Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.  [electronic resource] 

 -  BMC endocrine disorders  Feb 2018 
 - 14 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1472-6823 
<br/><br/><label>Standard No.: </label>10.1186/s12902-018-0243-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adamantane--analogs & derivatives<br/>Adult<br/>Age of Onset<br/>Biomarkers--analysis<br/>Blood Glucose--analysis<br/>Diabetes Mellitus, Type 2--diagnosis<br/>Dipeptides--therapeutic use<br/>Dipeptidyl-Peptidase IV Inhibitors--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Glycated Hemoglobin--analysis<br/>Glycemic Index<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin-Secreting Cells--drug effects<br/>Metformin--therapeutic use<br/>Polycystic Ovary Syndrome--drug therapy<br/>Prognosis<br/>Prospective Studies